Science Explorer Back to mapMap
Discussion
Company · Osaka · Japan

Sumitomo Dainippon Pharma (Japan)

In research, Sumitomo Dainippon Pharma (Japan) stands highest in Life Sciences (#5,923 of 11,023 worldwide), Biochemistry, Genetics and Molecular Biology (#4,036 of 5,801 worldwide) and Molecular Biology (#2,775 of 3,729 worldwide), over all time.

ds-pharma.com/index.htmlROR OpenAlex
World rank, 2022-now
#18,222
of 22,385 · #27,323 all time
Rank in Japan
#573
of 924
Research works
1.8k
▼ 25% vs 2018-21
Citations
41k
22.9 per fractional work
Top-10% rate
5.9%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
40%
world 40%
International
12%
world 18%
Sumitomo Dainippon Pharma (Japan)

What is Sumitomo Dainippon Pharma (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #5,923 of 11,023 6.2%771
Biochemistry, Genetics and Molecular BiologyField #4,036 of 5,801 6.9%415
Molecular BiologySubfield #2,775 of 3,729 7.1%279
MedicineField #11,565 of 14,558 4.9%577
Health SciencesDomain #13,486 of 16,688 5.0%604
NeuroscienceField #1,783 of 2,157 5.5%174
Organic ChemistrySubfield #1,569 of 1,832 6.7%246
ChemistryField #2,503 of 2,902 6.5%311
Physical SciencesDomain #17,354 of 17,446 6.2%414

Each strip is that field's whole ranked pool, with the notch where Sumitomo Dainippon Pharma (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Sumitomo Dainippon Pharma (Japan) work in?

In 2022-now, 50% of research at Sumitomo Dainippon Pharma (Japan) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (12%). It does 2.4× the world's share of Life Sciences.

Health Sciences: 42 fractional works · 49.8% of its workMedicine: 40 fractional works · 47.4% of its workPsychiatry and Mental health: 8 fractional works · 9.7% of its workOncology: 4 fractional works · 4.9% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 3.7% of its workNeurology: 3 fractional works · 3.6% of its workPharmacology: 3 fractional works · 3.3% of its workPhysiology: 2 fractional works · 2.9% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 2.5% of its workGenetics: 2 fractional works · 1.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.7% of its workHematology: 1 fractional works · 1.5% of its workNephrology: 1 fractional works · 1.3% of its workRheumatology: 1 fractional works · 1.2% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.2% of its workEpidemiology: 1 fractional works · 1.1% of its workSurgery: 1 fractional works · 1.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 0.9% of its workGastroenterology: 1 fractional works · 0.8% of its workOphthalmology: 1 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workTransplantation: 0 fractional works · 0.3% of its workFamily Practice: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 1.8% of its workGeneral Health Professions: 1 fractional works · 0.7% of its workSpeech and Hearing: 0 fractional works · 0.6% of its workComplementary and Manual Therapy: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.2% of its workLife Sciences: 31 fractional works · 37.3% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 16.0% of its workMolecular Biology: 11 fractional works · 12.9% of its workGenetics: 1 fractional works · 1.0% of its workBiochemistry: 0 fractional works · 0.5% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.3% of its workBiophysics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 10 fractional works · 12.5% of its workCellular and Molecular Neuroscience: 5 fractional works · 5.8% of its workCognitive Neuroscience: 2 fractional works · 2.9% of its workBiological Psychiatry: 1 fractional works · 1.1% of its workDevelopmental Neuroscience: 1 fractional works · 0.9% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.6% of its workSensory Systems: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 5 fractional works · 5.5% of its workImmunology: 4 fractional works · 5.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 3.0% of its workPharmacology: 1 fractional works · 1.4% of its workPharmaceutical Science: 1 fractional works · 1.1% of its workToxicology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workPhysical Sciences: 9 fractional works · 10.2% of its workEngineering: 4 fractional works · 4.3% of its workBiomedical Engineering: 2 fractional works · 2.7% of its workControl and Systems Engineering: 0 fractional works · 0.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.4% of its workChemistry: 3 fractional works · 3.8% of its workSpectroscopy: 1 fractional works · 1.6% of its workOrganic Chemistry: 1 fractional works · 1.0% of its workElectrochemistry: 0 fractional works · 0.4% of its workInorganic Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workEnvironmental Science: 1 fractional works · 1.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.7% of its workMaterials Science: 1 fractional works · 0.9% of its workMaterials Chemistry: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 2.7% of its workPsychology: 2 fractional works · 2.4% of its workClinical Psychology: 1 fractional works · 1.2% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workSocial Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.0% of its workALL ITS WORKSumitomoDainippon Pharma…84fractional works, 2022-now
Life Sciences37%Physical Sciences10%Health Sciences50%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine4047.4%
    2. Health Professions11.8%
    3. Veterinary00.4%
    4. Nursing00.2%
    1. Biochemistry, Genetics and Molecular Biology1316.0%
    2. Neuroscience1012.5%
    3. Immunology and Microbiology55.5%
    4. Pharmacology, Toxicology and Pharmaceutics33.0%
    5. Agricultural and Biological Sciences00.3%
    1. Engineering44.3%
    2. Chemistry33.8%
    3. Environmental Science11.0%
    4. Materials Science10.9%
    5. Computer Science00.1%
    6. Physics and Astronomy00.1%
    7. Mathematics00.0%
    1. Psychology22.4%
    2. Arts and Humanities00.2%
    3. Economics, Econometrics and Finance00.1%
    4. Social Sciences00.0%
    5. Decision Sciences00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.01× its world share, 13 worksBiochemistry, Geneti…Immunology and Microbiology: 5.42× its world share, 5 worksImmunology and Micro…Neuroscience: 7.70× its world share, 10 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.54× its world share, 2 worksPharmacology, Toxico…Chemistry: 2.41× its world share, 3 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.28× its world share, 4 worksEngineeringEnvironmental Science: 0.19× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.26× its world share, 1 worksMaterials ScienceMathematics: 0.03× its world share, 0 worksMathematicsPhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.67× its world share, 2 worksHealth ProfessionsMedicine: 2.47× its world share, 40 worksMedicineNursing: 0.41× its world share, 0 worksNursingVeterinary: 3.19× its world share, 0 worksVeterinaryArts and Humanities: 0.07× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.01× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.04× its world share, 0 worksEconomics, Econometr…Psychology: 0.78× its world share, 2 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.5×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics8.54×2 works
  2. Neuroscience7.70×10 works
  3. Immunology and Microbiology5.42×5 works
  4. Veterinary3.19×0 works
  5. Biochemistry, Genetics and Molecular Biology3.01×13 works
  6. Medicine2.47×40 works
  7. Chemistry2.41×3 works
  8. Psychology0.78×2 works
  9. Health Professions0.67×2 works
  10. Nursing0.41×0 works
  11. Engineering0.28×4 works
  12. Materials Science0.26×1 works
  13. Environmental Science0.19×1 works
  14. Arts and Humanities0.07×0 works
  15. Agricultural and Biological Sciences0.06×0 works
  16. Physics and Astronomy0.04×0 works
  17. Economics, Econometrics and Finance0.04×0 works
  18. Mathematics0.03×0 works
  19. Computer Science0.02×0 works
  20. Decision Sciences0.01×0 works

Who are the top researchers at Sumitomo Dainippon Pharma (Japan)?

Ranked on the quality score, Kazuhiko Horigome, Atsushi Kuwahara and Yasuji Furutani lead among researchers whose main affiliation is Sumitomo Dainippon Pharma (Japan).

  1. 1 Kazuhiko Horigome Japan · #580,955 worldwide 2k citations · 31 works
  2. 2 Atsushi Kuwahara Japan · #1,017,984 worldwide 2.3k citations · 54 works
  3. 3 Yasuji Furutani Japan · #1,494,288 worldwide 6.1k citations · 40 works
  4. 4 Suguru Yamasaki Japan · #1,778,404 worldwide 1k citations · 36 works
  5. 5 Toshihiko Fujii Japan · #1,803,525 worldwide 3.6k citations · 240 works
  6. 6 Hayao Ebise Japan · #2,157,944 worldwide 900 citations · 15 works
  7. 7 Mitsue Notake Japan · #2,279,246 worldwide 2k citations · 23 works
  8. 8 Keizo Matsushita Japan · #2,394,125 worldwide 710 citations · 17 works
  9. 9 Atsushi Tsuchida Japan · #2,563,448 worldwide 8.6k citations · 48 works
  10. 10 Hitoshi Ban Japan · #2,661,896 worldwide 1.1k citations · 37 works
All ranked researchers at Sumitomo Dainippon Pharma (Japan)

What are the most cited papers from Sumitomo Dainippon Pharma (Japan)?

The most cited paper from Sumitomo Dainippon Pharma (Japan) is "Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells" (Nobuyoshi Kosaka, Haruhisa Iguchi, Yusuke Yoshioka et al., 2010), with 1,977 citations. Next come "Fgf10 is essential for limb and lung formation" (1,251) and "Heat-Evoked Activation of the Ion Channel, TRPV4" (1,036).

Most cited papers
#PaperReleasedCitations
1 Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells Nobuyoshi Kosaka, Haruhisa Iguchi, Yusuke Yoshioka et al. · Journal of Biological Chemistry Open access 30 Mar 2010 1,977
2 Fgf10 is essential for limb and lung formation Keisuke Sekine, Hideyo Ohuchi, Masanori Fujiwara et al. · Nature Genetics 1999 1,251
3 Heat-Evoked Activation of the Ion Channel, TRPV4 Ali D. Güler, Hyosang Lee, Tohko Iida et al. · Journal of Neuroscience Open access Aug 2002 1,036
4 Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis Nobuyoshi Kosaka, Haruhisa Iguchi, Keitaro Hagiwara et al. · Journal of Biological Chemistry Open access 26 Feb 2013 795
5 Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli Hisahiro Yoshida, Mayumi Bogaki, Mami Nakamura et al. · Antimicrobial Agents and Chemotherapy Open access Aug 1991 780
All 60 most cited papers, with filters and sorting

Which keywords describe research at Sumitomo Dainippon Pharma (Japan)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Metabolic Syndrome, Inflammation, Social Cognition, Cognitive Therapy, Antipsychotic Drugs, Neurocognitive Deficits, Depression and Oxidative Stress.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation8▲ 4.2×29 topics
  2. Metabolic Syndrome6▲ 8.7×7 topics
  3. Oxidative Stress5▲ 3.9×17 topics
  4. Depression4▲ 6.0×12 topics
  5. Social Cognition4▲ 28×2 topics
  6. Cardiovascular Disease4▲ 4.3×12 topics
  7. Antipsychotic Drugs4▲ 123×1 topic
  8. Cognitive Therapy4▲ 44×2 topics
  9. Neurocognitive Deficits4▲ 123×1 topic
  10. Neurological Disorders4▲ 7.9×7 topics
  11. Neurodegeneration4▲ 14×8 topics
  12. Clinical Guidelines3▲ 14×4 topics
  13. Genetics3▲ 5.8×7 topics
  14. Synaptic Plasticity3▲ 18×4 topics
  15. Cancer3▲ 2.7×20 topics
  16. Neuroimaging3▲ 12×5 topics
  17. Neurobiology3▲ 12×5 topics
  18. Tumor Microenvironment3▲ 7.0×5 topics
  19. Mitochondrial Dysfunction2▲ 10×5 topics
  20. Cancer Immunotherapy2▲ 18×3 topics
  21. Genetic Variation2▲ 13×4 topics
  22. Prevalence2▲ 6.6×4 topics
  23. Cognitive Impairment2▲ 10×5 topics
  24. Emotion Regulation2▲ 8.2×4 topics
  25. Parkinson's Disease2▲ 11×3 topics
  26. Cognitive Function2▲ 14×4 topics
  27. Immune Checkpoint Blockade2▲ 22×1 topic
  28. Immunity2▲ 6.3×4 topics
  29. Neuroinflammation2▲ 8.8×4 topics
  30. PD-1 and PD-L12▲ 22×1 topic
  31. Pluripotent Stem Cells2▲ 48×2 topics
  32. Gene Therapy2▲ 13×3 topics
  33. Innate Immunity2▲ 7.5×6 topics
  34. Treatment-Resistant Depression2▲ 36×2 topics
  35. Glycemic Control2▲ 14×3 topics
  36. Insulin Therapy2▲ 18×3 topics
  37. Bipolar Spectrum Disorder2▲ 95×1 topic
  38. NMDA Receptor2▲ 54×2 topics
  39. Suicide Risk2▲ 69×1 topic
  40. Treatment Guidelines2▲ 10×2 topics

Which research topics does Sumitomo Dainippon Pharma (Japan) publish most on?

By volume in 2022-now: Schizophrenia research and treatment, Cancer Immunotherapy and Biomarkers, Bipolar Disorder and Treatment and Parkinson's Disease Mechanisms and Treatments.

Schizophrenia research a…4Schizophrenia research and treatment: 4 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksBipolar Disorder and Treatment: 2 fractional worksParkinson's Disease Mechanisms and Treatments: 2 fractional worksTreatment of Major Depression: 2 fractional worksImmunotherapy and Immune Responses: 1 fractional worksNeuroscience and Neuroph…1Neuroscience and Neuropharmacology Research: 1 fractional worksRetinal Development and Disorders: 1 fractional worksDiabetes Treatment and Management: 1 fractional worksPhotoreceptor and optoge…1Photoreceptor and optogenetics research: 1 fractional works
Psychiatry and Mental healthOncologyNeurologyPharmacology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Schizophrenia research and treatment Psychiatry and Mental health 4 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Bipolar Disorder and Treatment Psychiatry and Mental health 2 works
  4. 4 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
  5. 5 Treatment of Major Depression Pharmacology 2 works
  6. 6 Immunotherapy and Immune Responses Immunology 1 works
  7. 7 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  8. 8 Retinal Development and Disorders Molecular Biology 1 works
  9. 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  10. 10 Photoreceptor and optogenetics research Cellular and Molecular Neuroscience 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 40% of research is openly available.

with international co-authors11.9%domestic only88.1%

World: 18% is written across borders.

How has Sumitomo Dainippon Pharma (Japan)'s research output changed?

Output in 2022-2025 was 25% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sumitomo Dainippon Pharma (Japan) as a percentage of every work published that year, 0.00039% in 2024.

still counting0.0050%0.010%Sumitomo Dainippon Pharma (Japan)0.00034% in 202519801990200020102020

Fractional works of Sumitomo Dainippon Pharma (Japan) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting5%10%15%all institutions10.0% in 2025Sumitomo Dainippon Pharma (Japan)6.4% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 13.5% in 2014.

Other research institutions in Osaka

All research institutions in Osaka

Share Sumitomo Dainippon Pharma (Japan)'s ranking

Sumitomo Dainippon Pharma (Japan) on Science Explorer

A card with Sumitomo Dainippon Pharma (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sumitomo Dainippon Pharma (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.